However, tumor-associated NK cells, identified as CD3–CD56+ cells, were barely characterized phenotypically in that study and the possible anti-tumor role of tumor-infiltrating PD-1+ NK cells was not considered. The gene discussed is NCAM1; the disease is neoplasm.